Zanskar Secures Rs 2.8 Crore in Seed Funding

Zanskar, a prominent pain-care and wellness brand based in Gurugram, has successfully acquired Rs 2.8 crore in seed funding. This funding round was led by Zeropearl VC, with notable participation from angel investors such as Pawan Gupta from Fashinza, Amit Baid from 10X Growth Ventures, and Nidhish Mundra from Oaktree Capital.

Utilisation of Funds

The newly acquired capital will be directed towards broadening Zanskar’s product line, enhancing research and development, and boosting marketing efforts across various digital platforms. Additionally, Zanskar aims to strengthen its offline retail presence while continuing to grow its direct-to-consumer (D2C) operations.

About Zanskar’s Founders

Zanskar was founded by IIT Delhi alumni Anshul Mittal and Manu Mittal. The brand’s offerings include a joint pain cream enriched with Vitamin B6 and a magnesium-infused roll-on for migraine relief. The company has already attracted over 50,000 customers throughout India who have experienced Zanskar’s products.

Future Aspirations

Looking forward, Zanskar is developing new product formats aimed at arthritis and muscle recovery. The company is also planning to enhance its AI-driven physiotherapy app and is exploring the introduction of wellness centres in various metropolitan areas.

Availability of Products

Currently, Zanskar’s offerings can be found on its official website as well as on popular platforms such as Blinkit, Tata 1mg, Amazon, and Flipkart.

Market Insights

According to market research, the pain-care market is projected to reach nearly Rs 16,000 crore by 2025, growing at an annual rate of 18% over the last five years. This growth rate is almost threefold compared to the overall over-the-counter (OTC) market.